Recent evidence indicates that both events can be induced by antibody-mediated cross-linking of a sperm surface progesterone receptor. In many other systems in which signal is generated by receptor cross-linking, protein phosphorylation on tyrosine residues is involved in the signal transduction across the plasma membrane.
In this study we examined whether tyrosine phosphorylation is implicated in the function of the sperm surface progesterone receptor, too. The effect of progesterone on the phosphorylation of proteins from a sperm membrane lysate was evaluated by in vitro kinase assay and by phosphoamino acid analysis using [r-'"PIATP as precursor.
These experiments revealed a selective increase in the tyrosine phosphorylation of a 94-kilodalton phosphoprotein in the presence of progesterone.
To decide whether the progesterone-induced increase in protein tyrosine phosphorylation is actually due to the hormone action on the cell surface, living sperm were treated with a cell-impermeant progesterone receptor agonist, and the resulting changes in the cellular level of phosphotyrosine proteins were examined. These experiments showed a clear relationship between the agonist binding and an increase in the phosphotyrosine concentration in the respective cells. This relationship was lost in the presence of genistein, which also efficiently inhibited the phosphorylation of the 94-kilodalton protein and the progesteroneinduced acrosomal exocytosis. These results lead to the hypothesis that protein tyrosine phosphorylation is involved in signal transduction through the sperm surface progesterone receptor and may be implicated in nongenomic steroid effects in other cell types. (Endocrinology 133: 32%335,1993) 0 VER the past 10 yr, there has been increasing evidence suggesting that steroids can exert rapid nongenomic effects in a variety of animal cells, such as neurons (l-3), pituitary cells (4, 5), heart (6), and skeletal muscle (7) myocytes, leukocytes (8), bone cells (9), intestinal cells (lo), ovarian granulosa cells (1 l), oocytes (12), or prostatic carcinoma cells (13) , by acting at receptors on the cell surface. The existence of this type of receptor in human sperm was suggested in the late 1980s by studies demonstrating a rapid influx of extracellular Ca*+ ions into sperm cells exposed to progesterone (14) (15) (16) (17) . Subsequent studies have confirmed this concept by using cell-impermeant progesterone conjugates instead of unbound free hormone (18) (19) (20) . The Ca*' influx into sperm is a prerequisite for the acrosome reaction, an egg-induced exocytotic event necessary for fertilization (21) . Since progesterone is present in the cumulus oophorus, the outer part of the egg coat, in sufficient quantities to elicit the Ca*+ influx into sperm (14), a sperm surface progesterone receptor appears to be involved in the control of the acrosome reaction by the egg. Preliminary clinical data suggest that a defective function of this receptor may be related to human infertility (22) .
Notwithstanding the possible clinical importance of the sperm surface progesterone receptor, mature sperm cells represent an interesting model for the study of cell-surface steroid receptors because the transcriptional activity of these cells is arrested, and eventual superimposition of genomic and nongenomic effects can thus be excluded. However, the problem of the molecular identity of the sperm surface progesterone receptor has not yet been resolved, nor is it understood what mechanisms are involved in signal transduction from the receptor to intracellular effecters of the acrosomal exocytosis. A new insight into the function of this receptor was provided recently by a study in which the progesterone-induced Ca '+ influx and the acrosomal exocytosis were produced by antibody-mediated cross-linking of hormone-receptor complexes on the sperm surface (23). In many other cell types in which signal transduction is initiated by receptor cross-linking, the propagation of the signal transmission cascade involves activation of protein phosphorylation on tyrosine residues, either by a protein tyrosine kinase (PTK) domain of the receptor molecule (24) or by a nonreceptor PTK associating with the cross-linked ligand-receptor complexes (25). A question then arises whether protein tyrosine phosphorylation is implicated in signal transduction through the sperm surface progesterone receptor, too.
Membrane phosphotyrosine proteins of human sperm were identified recently, and one of them [94 rfr 3 kilodaltons (kDa)] was shown to be autophosphorylated on tyrosine residues in response to acrosome reaction-stimulating proteins from the outer part of the egg coat (the zona pellucida), 
Results

Effect of progesterone on in vitro autophosphorylation of sperm proteins
When the autophosphorylation ability of proteins from the sperm membrane lysate was evaluated by an in vitro kinase assay, a single autophosphorylated protein of 94 kDa was consistently detected, in addition to a group of various autophosphorylated proteins in the 40-to 60-kDa region of the gels (Fig. 1) . When we compared the degree of autophosphorylation of the 94-kDa protein in the presence of progesterone with those in control incubations, a perceptible increase was evident in the progesterone-treated samples (Fig. 1) . To decide whether this increase was selective for the 94-kDa protein or whether it also occurred in the other autophosphorylated proteins, we compared quantitatively the incorporation of [Y-~~P]ATP into the 94-kDa protein with that into proteins of the 40-to 60-kDa group (see Fig. 1 autophosphorylation of the 94-kDa protein, whereas the intensity of autophosphorylation of the proteins in the 40-to 60-kDa region was independent of the presence of progesterone (Fig. 2) . Phosphoamino acid analysis showed that almost all of the phosphorylation of the 94-kDa protein in the presence of progesterone was on tyrosine, whereas most of the phosphorylation of the 40-to 60-kDa proteins was on serine and only a small part on tytisine (Table 1) .
Genistein-sensitive effect of a cell-impermeant progesterone receptor agonist on the abundance of phosphotyrosine residues in intact sperm cells (22, 32) . When the abundance of phosphotyrosine residues in these cells was evaluated in double-fluorescence experiments using antiphosphotyrosine monoclonal antibody (Fig. 3) , 95 + 2% (mean + SE, n = 5) of the cells binding the agonist showed an intense fluorescence of the sperm head with the antiphosphotyrosine antibody. Inversely, only about 11% of all sperm cells in these preparations showed a bright fluorescence of the sperm head with the antiphosphotyrosine antibody, but 84 + 4% (mean + SE, n = 5) of these antibody-reactive cells also bound the progesterone receptor agonist. External Ca*+ ions were not required for the activation of protein tyrosine phosphorylation by the bound agonist, since the typical association of progesterone-BSA binding with increased abundance of cellular phosphotyrosine proteins was seen in cells incubated with the agonist in Ca"-containing (Fig. 3, A and B) as well as in Ca'+-free (Fig. 3 , C and D) medium. Most of the sperm cells were not labeled specifically with either probe. When the antiphosphotyrosine antibody was applied on cells that were not previously exposed to the progesterone receptor agonist, the brightly fluorescent cells were seen rarely (~2% of the sperm populations). The levels of nonspecific fluorescence for FITC-labeled progesterone-BSA and for antiphosphotyrosine antibody were assessed in controls using FITClabeled BSA alone and antiphosphotyrosine antibody previously saturated with 0-phosphotyrosine, respectively. Preincubation of sperm with the PTK inhibitor genistein did not influence the percentage of cells binding FITClabeled progesterone-BSA, but it reduced severely the percentage of the agonist-binding cells showing at the same time the heavy labeling with antiphosphotyrosine antibody as compared with the control (Fig. 4) . With the highest genistein concentration (100 pg/ml), only few cells were labeled with antiphosphotyrosine antibody (like in sperm populations that were not exposed to the agonist), and most of these cells did not bind progesterone-BSA, The association of labeling with both probes, typical of control samples, was an exceptional finding under these conditions. This effect of genistein was not due to nonspecific cellular damage because the drug did not affect either sperm viability or sperm movement even at the highest concentration used in this study ( Table 2 ). The specificity of the genistein effect is supported by the observation of a significant, though not complete, inhibition of the autophosphorylation of sperm proteins, Magnification, x1000. particularly the 94-kDa protein, in the presence of the drug (Fig. 5) .
Effect of genistein on the acrosome reaction induced by a cellimpermeant progesterone receptor agonist
In preliminary experiments, no apparent effect of genistein on the percentage of acrosome-reacted sperm was found when the incubation with the inhibitor was carried out in the absence of the progesterone receptor agonist (Table 2) . When sperm were preincubated with genistein and then exposed to FITC-labeled agonist, progesterone-BSA, no effect on the percentage of sperm cells binding the agonist was observed; however, genistein inhibited the progesteroneinduced acrosome reaction in a concentration-dependent manner (Fig. 6) The increase in the phosphorylation of the 94-kDa protein in the presence of progesterone was apparently due to phosphorylation on tyrosine residues as shown by the results of phosphoamino acid analysis. Since the analysis of gel autoradiographs after the in vitro kinase assay showed consistently a single protein band in the 94-kDa position, and no other phosphorylated proteins were detected in the nearby gel regions, it is highly probable that the 94-kDa phosphoprotein seen in this study is identical with the phosphoprotein of the same molecular size detected by Naz et al. (26) . However, until direct evidence for this is available, some caution as to the comparison of the data described in both studies is appropriate.
The relative increase in the phosphorylation of the 94-kDa protein was similar to that occurring in response to the zona pellucida proteins (26). Moreover, in the case of progesterone, the physiological significance of this increase is potentiated by the fact that only about 10% of sperm from normal healthy men express a functional progesterone receptor on the cell surface (32). The perceived increase in the autophosphorylation intensity would thus probably be much more considerable if only progesterone-responsive cells could be isolated for this kind of analysis.
The biological significance of the observed restriction of the active progesterone receptor to about 10% of human spermatozoa is not known and can only be a subject of speculation.
If this selectivity means that some 90% of spermatozoa are inherently incapable of the receptor expression, and assuming that the receptor is important for fertilization, the labeling of spermatozoa with fluorochrome-labeled progesterone-protein conjugates may become a useful method for the distinction of potentially fertilizing spermatozoa in many clinical and research applications.
On the other hand, the actual lack of the progesterone receptor might be related to a temporary functional state of the sperm cell so that different progesterone-responsive sperm subpopulations might appear and disappear with time. In this case, the temporary inability of spermatozoa to respond to progesterone might protect them from a premature acrosome reaction and so ensure a longer persistence of potentially fertilizing spermatozoa in the female genital tract. Experiments are in progress in our laboratories to decide between these two possibilities.
Even though the experiments using the in vitro kinase assay and phosphoamino acid analysis (see above) showed clearly that progesterone increases the tyrosine phosphorylation of a phosphotyrosine protein, they did not show directly whether this increase was actually mediated by a cellsurface receptor. The specificity of this antibody reaction was confirmed by the disappearance of antibody reactivity with the agonist-binding cells after previous antibody absorption with 0-phosphotyrosine. At first sight, the increase in the reactivity of progesterone binding cells with antiphosphotyrosine antibody may appear surprisingly high, given the fact that only about 13% of total sperm protein phosphorylation was in the 94-kDa protein, and the progesterone-induced increase in the phosphorylation of this protein was only about 40% above the control level. However, the immunofluorescence findings become more understandable when we realize that almost all of the phosphorylation of the 94-kDa protein is on tyrosine residues, whereas most of the phosphorylation of the 40-to 60-kDa proteins is on serine and only a small part on tyrosine. Furthermore, since only about 10% of the cells bind and respond to progesterone (see above), the progesterone effect is diluted by the contribution from the prevailing nonresponsive cells when it is studied in membrane lysates from the total sperm population (as was the case with the in vitro kinase assay) as compared with the undiluted effect observed in the fluorescence microscopy experiments in which only the progesterone-responsive sperm cell subpopulation was taken into account. Therefore, the progesterone effects observed in this study in sperm membrane lysates are in agreement with the observations on intact living sperm cells, and both are consistent with the contention that progesterone stimulates protein tyrosine phosphorylation by acting at a sperm surface receptor. To evaluate the biological significance of the changes in the metabolism of phosphotyrosine proteins in response to progesterone receptor activation, we examined the effect of the PTK inhibitor genistein (33) on a progesterone-induced exocytotic event, the acrosome reaction. These experiments showed a dose-dependent inhibition of the exocytotic response in the presence of genistein, although the response was not abolished completely even with the highest inhibitor concentration used. Under the same conditions, genistein has been reported to cause a virtually complete inhibition of the in vim phosphorylation of the epidermal growth factor receptor in human epidermoid carcinoma cells (33). The incomplete character of the inhibitory effect of genistein observed in our system can be explained by the persistence of residual PTK activity in genistein-treated cells. As shown in Fig. 5 , the intensity of the phosphorylation of the 94-kDa protein in the presence of the highest genistein concentration used in this study (100 @g/ml) was still about 25% of the control level. Since 98.5% of the phosphorylation of this protein is on tyrosine residues, this means that the PTK inhibition with this concentration of genistein is not complete. Thus, the level of phosphotyrosine proteins in some of genisteintreated cells may have been sufficient to ensure the biological response, although it was insufficient to be detected by the immunocytochemical method used in this study. However, it may also be that the PTK-employing system is only one component of a complex mechanism controlling the acrosoma1 exocytosis (34), and that this event can be mediated, under certain conditions, by a PTK-independent mechanism. These two concepts are not necessarily incompatible, since a PTK-independent mechanism may decide whether a given concentration of phosphotyrosine proteins will be sufficient or not for the exocytotic response.
The present observation of the dissociation between the binding of the FITC-labeled progesterone receptor agonist and the increase in the concentration of phosphotyrosine residues after sperm preincubation with genistein is another argument reinforcing the concept of PTK implication in the function of the sperm progesterone receptor. Under in vitro conditions, genistein has been shown to inhibit selectively tyrosine-specific protein kinases, both of the receptor and nonreceptor type, and to lack an inhibitory effect on serineand threonine-specific protein kinases, such as CAMP-dependent protein kinase, phosphorylase kinase, and Ca'+/ phospholipid-dependent protein kinase C (33). When cells are exposed to genistein in vivo, however, the phosphorylation on serine and threonine residues can also be affected (33). Moreover, a recent finding that genistein inhibits postreceptor effects of insulin in rat adipocytes without inhibiting the insulin receptor kinase (35) warns against the interpretation of any effect of this drug as due to PTK inhibition unless this mechanism is specifically demonstrated. In this study we did not examine directly the in viva effect of genistein on PTK activity, and the interpretation of the effects of genistein on the progesterone-induced exocytosis (the acrosome reaction) thus relies, in addition to the above immunofluorescent findings, on the demonstration of the in vitro inhibitory effect of genistein on the phosphorylation of proteins from sperm membrane lysate, and particularly of the 94-kDa PTK substrate. This view is supported by the demonstrated absence of toxic effects of the inhibitor on sperm cells as well as of its direct effects on the acrosome reaction.
The present findings help to understand the mechanism by which the acrosome reaction, a central event in fertilization, is controlled by components of the egg coat. Another component of the egg coat, the zona pellucida protein termed ZP3, has also been shown to aggregate a receptor on the surface of the mouse sperm (36) and to stimulate protein tyrosine phosphorylation leading to acrosomal exocytosis (37). Human zona pellucida proteins are known to stimulate protein tyrosine phosphorylation in human sperm (26) and to initiate the acrosomal exocytosis (38), although the active factor has not yet been identified. The acrosome reaction of human sperm is thus controlled by at least two ligandreceptor systems, the activation of which converges at the postreceptor level toward the same effector system, triggering the exocytotic response. It remains to be elucidated how these two systems cooperate under physiological conditions to ensure a properly timed acrosome reaction necessary for fertilization. Research aimed at the understanding of this mechanism is expected to bring new tools for the diagnosis of human infertility and to provide information potentially applicable in the development of new contraceptive techniques.
Outside the sphere of reproductive biology, the present findings open the question of whether protein tyrosine phosphorylation is implicated in signal transduction through cell surface steroid receptors in other cell types in which rapid, nongenomic actions of steroids have been demonstrated. Various second messenger systems have been shown to be modulated by steroid action on cell surface receptors. In the amphibian oocyte, for instance, progesterone activates a system generating diacylglycerol through phospholipase C-mediated hydrolysis of phosphatidylcholine (39), whereas it inhibits another system regulating the activity of membranebound adenylate cyclase (40). A decrease in CAMP production has also been observed in pituitary cells in response to cortisol, another steroid hormone supposed to produce a nongenomic effect by acting at a cell surface receptor (41). It is tempting to speculate that cell surface steroid receptors in various cell types share a common strategy of their function. It remains to be ascertained whether such a common strategy really exists and whether it involves the employment of protein tyrosine phosphorylation in the signal transduction mechanism. 
